Ability of chitosan gels to disrupt bacterial biofilms and their applications in the treatment of bacterial vaginosis

Journal of Pharmaceutical Sciences

Volumn 102, Issue 7, 2013, Pages 2096-2101

  Kandimalla, Karunya K ^a,b   Borden, Emma ^b   Omtri, Rajesh S ^a,b   Boyapati, Siva Prasad ^a   Smith, Michael ^b   Lebby, Kimberly ^b   Mulpuru, Maanavi ^c   Gadde, Mounika ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

Author keywords

Absorption; bacterial vaginosis; Biofilm; Carbopol; Chitosan; Hydrogels; Microscopy; Mucosal drug delivery

Indexed keywords

CHITOSAN; CRYSTAL VIOLET; METRONIDAZOLE; POLYCARBOPHIL; POLYMER; PROPIDIUM IODIDE;

ARTICLE; BACTERIAL GROWTH; BIOFILM; CONFOCAL MICROSCOPY; DRUG EFFICACY; DRUG FORMULATION; NONHUMAN; PH; PSEUDOMONAS AERUGINOSA; VAGINITIS;

EID: 84879027165     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23571     Document Type: Article

References (17)

1. Sobel JD. 2000. Bacterial vaginosis. Annu Rev Med 51(1):349-356.
2. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. 1992. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 79(3):369-373.
3. Joesoef MR, Schmid GP. 1995. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 20 Suppl 1:S72-S79.
4. Ferris DG, Hendrich J, Litaker MS, Mathis D, Woodward L. 1995. Treatment of bacterial vaginosis: A comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 11:443-449.
5. Ahmed-Jushuf IH, Shahmanesh M, Arya OP. 1995. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: Results of a multicentre, double blind, placebo controlled trial. B V Investigators Group. Genitourin Med 71(4):254-256.
6. Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dorffel Y, Scholze J, Lochs H, Verstraelen H. 2008. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198(1):97 e1-97 e6.
7. Khoury AE, Lam K, Ellis B, Costerton JW. 1992. Prevention and control of bacterial infections associated with medical devices. Asaio J 38(3):M174-M178.
8. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: A common cause of persistent infections. Science 284(5418):1318-1322.
9. Gristina A. 1987. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 237(4822):1588-1595.
10. Nickel JC, Ruseska I, Wright JB, Costerton JW. 1985. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27(4):619-624.
11. Wain AM. 1998. Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): A brief review. Infect Dis Obstet Gynecol 6(1):3-7.
12. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. 2003. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 4 (6):1457-1465.
13. Carlson RP, Taffs R, Davison WM, Stewart PS. 2008. Anti-biofilm properties of chitosan-coated surfaces. J Biomater Sci Polym Ed 19(8):1035-1046.
14. Pasquantonio G, Greco C, Prenna M, Ripa C, Vitali LA, Petrelli D, Di Luca MC, Ripa S. 2008. Antibacterial activity and anti-biofilm effect of chitosan against strains of Streptococcus mutans isolated in dental plaque. Int J Immunopathol Pharmacol 21(4):993-997.
15. Ugwumadu A. 2007. Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. Best Pract Res Clin Obstet Gynaecol 21(3), 391-402.
16. Kohlberger P, Bancher-Todesca D. 2007. Bacterial colonization in suspected sexually abused children. J Pediatr Adolesc Gynecol 20(5):289-292.
17. Martinez LR, Mihu MR, Han G, Frases S, Cordero RJ, Casadevall A, Friedman AJ, Friedman JM, Nosanchuk JD. 2010. The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31(4):669-679.